2022 Capital Markets Day presentation

ROVI updates its strategy in a meeting with shareholders, investors and analysts


TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION

(COMISIÓN NACIONAL DEL MERCADO DE VALORES)

Madrid, 23 November 2022

In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold an in-person and virtual meeting today with analysts and investors to present said presentation.

 

Mr. Juan López-Belmonte Encina

Chairman and Chief Executive Officer

Laboratorios Farmacéuticos ROVI, S.A.

 

No votes yet
 
Related
Glicopepton Biotech founded to produce compounds of high technological value   · ROVI, Càrniques Celrà and Grupo Costa announce...
3 min
04/10/2022
ROVI tops the Sustainalytics sustainability ranking for the pharmaceutical subindustry worldwide Laboratorios Farmacéuticos ROVI...
2 min
01/08/2022
ROVI REPORTS OPERATING REVENUE GROWTH OF 31% AND NET PROFIT GROWTH OF 58%   Operating revenue increased by 31% to 380.4...
3 min
27/07/2022